Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002568012 | SCV003461754 | pathogenic | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2022-10-03 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GRIN2B protein function. ClinVar contains an entry for this variant (Variation ID: 1164046). This missense change has been observed in individual(s) with clinical features of GRIN2B-related conditions (PMID: 30151416). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 643 of the GRIN2B protein (p.Leu643Pro). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV003156347 | SCV003845473 | pathogenic | not provided | 2022-09-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30151416, 27839871) |
Pediatric Genetics Clinic, |
RCV001788528 | SCV001712183 | likely pathogenic | Intellectual disability, autosomal dominant 6 | 2021-05-13 | no assertion criteria provided | clinical testing |